Navigation Links
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting

bout the future of this new anticancer drug candidate," said Lorianne Masuoka, M.D., Senior Vice President and Chief Medical Officer.  

Side effects were generally manageable with dose-limiting toxicity consisting primarily of Grade 3 diarrhea (20-23%) typically occurring after three months of therapy for both schedules.   Neuropathy and alopecia were minimal with only one patient experiencing G2 alopecia in the study.  Both neuropathy and alopecia are significant adverse events commonly associated with standard breast cancer therapies [Safety Tables, Figures D and E].

NKTR-102 Phase 2 Data Presentation in Metastatic Breast Cancer

  • Awada et. al., Antitumor activity in a randomized phase II study comparing two schedules of NKTR-102 in patients (Pts) with pretreated metastatic breast cancer (MBC).Abstract #1034, Poster Board #24Poster Discussion Session:  Breast Cancer - Triple-negative/Cytotoxics/Local Therapy  Session Date and Time:  Saturday, June 4, 2011, 2:00 PM – 6:00 PM, Central TimeLocation:  E450bFigure A: Efficacy Table: Objective Tumor Response Rate by RECIST (Investigator Assessment)Response by RECIST v 1.0NKTR-102145 mg/m2q14d NKTR-102145 mg/m2q21d TOTALN



    66ORR (confirmed + unconfirmed)

    11 (35%)

    11 (31%)

    22 (33%)ORR (confirmed)

    10 (32%)

    9 (26%)

    19 (29%)CR (confirmed)

    2 (7%)


    2 (3%)PR (confirmed)

    8 (26%)

    9 (26%)

    17 (26%)SD

    12 (39%)

    16 (46%)

    28 (42%)PD

    9 (29%)

    10 (29%)

    19 (29%)Median duration of response

    8.3 months

    4.4 months

    5.8 monthsClinical benefit

    (CR+PR+SD>6 months)

    13 (42%)

    17 (49%)

    30 (46%)Median progression-free survival**

    3.5 months

    5.3 months

    4.6 monthsMedian overall survival**

    8.8 months

    13.1 months

    10.3 months

  • SOURCE Nektar Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
    2. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
    3. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
    4. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
    5. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
    6. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
    7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
    8. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
    9. NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
    10. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
    11. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
    Post Your Comments:
    (Date:10/1/2015)... The major trend driving the Respiratory Devices market is the ... UK Respiratory Device market is currently estimated to be valued ... to reach $0.999 billion by the end of 2019. The ... 12.02%. This escalation is developing the need to analyze, ... device market. Owing to the rapid evolution of market in ...
    (Date:10/1/2015)... , Oct. 1, 2015 Physica ... Summary Global Markets Direct,s, ,Physica Pharma ... an overview of the Physica Pharma SAS,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... at various stages, therapeutics assessment by drug target, ...
    (Date:10/1/2015)... The report will be delivered in PDF ... If print or CD-Rom version purchased, the report will ... Alzheimer,s Disease Partnering 2010-2015 report provides understanding and access ... into by the worlds leading healthcare companies. Trends ... by value Deals listed by company A-Z, industry sector, ...
    Breaking Medicine Technology:UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020) 2UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020) 3Physica Pharma SAS - Product Pipeline Review - 2015 2Physica Pharma SAS - Product Pipeline Review - 2015 3Physica Pharma SAS - Product Pipeline Review - 2015 4Global Alzheimer's Disease Partnering 2010-2015 2Global Alzheimer's Disease Partnering 2010-2015 3Global Alzheimer's Disease Partnering 2010-2015 4
    ... 6, 2011 Decision Diagnostics Corp., formerly known as ... diagnostics, home testing products for the chronically ill, a ... and a leading developer of revolutionary cell phone centric ... the Board of Directors has approved the payment of ...
    ... BETHESDA, Md., Dec. 6, 2011 /PRNewswire-Asia/ -- Chindex International, ... care company providing health care services in China through ... private primary care hospitals and affiliated ambulatory clinics, today ... Annual Oppenheimer Healthcare Conference, to be held December 13-14, ...
    Cached Medicine Technology:Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend 2
    (Date:10/2/2015)... ... October 02, 2015 , ... The U.S. Food ... drug Keytruda (pembrolizumab) for the treatment of advanced non-small cell lung cancer (NSCLC) ... was approved along with the first companion diagnostic to detect PD-L1 expression in ...
    (Date:10/2/2015)... ... October 02, 2015 , ... For more than 25 ... growth and acknowledged the CEOs who have shepherded that growth. In recognition ... Pentec Health, will be inducted into the Philly 100® CEO Hall of Fame ...
    (Date:10/2/2015)... ... October 02, 2015 , ... With Hurricane Joaquin taking an uncertain path ... Amica Insurance is sharing safety tips to help gear up for potentially severe ... wind speeds of approximately 130 mph. Amica is sharing the following tips from FEMA ...
    (Date:10/2/2015)... (PRWEB) , ... October 02, 2015 , ... ... premier nonprofit educational organization and the educational arm of the League of United ... (WYLS). The week-long event is a life-changing opportunity for Latino high school students ...
    (Date:10/2/2015)... ... October 02, 2015 , ... For more than a ... to West Orange, Livingston, and all of North Jersey, seeking more to restore ... of this year, the team at Advanced Dermatology continued this commitment to innovation ...
    Breaking Medicine News(10 mins):Health News:New Immunotherapy for Lung Cancer Offers Hope to Patients, SITC Reacts 2Health News:New Immunotherapy for Lung Cancer Offers Hope to Patients, SITC Reacts 3Health News:Joe Cosgrove to be Inducted into Philadelphia 100® CEO Hall of Fame Society 2Health News:Prepare for Hurricane Joaquin with 8 Tips from Amica Insurance 2Health News:LNESC Kicks Off 18th Annual Youth Leadership Conference 2Health News:LNESC Kicks Off 18th Annual Youth Leadership Conference 3Health News:Microneedling for New Jersey: Dr. Rachael Hartman Introduces a New Dermatology Treatment to West Orange for September 2Health News:Microneedling for New Jersey: Dr. Rachael Hartman Introduces a New Dermatology Treatment to West Orange for September 3
    ... soon be overcome by a newly developed vaccine according ... receiving funds from the government, said that their vaccine ... in mice. This bacteria causes a range of potentially ... ,Most hospital-acquired infections are commonly caused by it, ...
    ... of schizophrenia can be relieved by music therapy.// ... study in 4 hospitals and found improvement in the ... express themselves through music. ,"We have known ... with schizophrenia, but these have only been used when ...
    ... A tiny human liver has been grown from umbilical cord ... This eliminates //the need for animal experiments for drug testing. ... size of a 1p coin, is just the initial phase ... mend damaged liver and also a mature functioning form. ...
    ... risk of cot death or sudden infant death syndrome (SIDS) ... temperature control. // ,U.S. researchers conducted the study ... in the Journal of the American Medical Association, in which, ... their brainstem that affected the processing of the chemical called ...
    ... Louis University Liver Center scientists are presenting research today ... patients who have been unresponsive to current// drug therapies. ... of ribavirin and Infergen, a highly potent Interferon, is ... standard treatments. They are sharing their findings at the ...
    ... close relatives suffering from breast cancer but who may not ... still have a// higher than average risk of developing the ... test negative for the BRCA1 and BRCA2 faults, they may ... cancer by the age of 50 than other women. ...
    Cached Medicine News:Health News:Vaccine may overcome Common Infections: Researchers 2Health News:Artificial Liver from Cord Blood Stem cells 2Health News:Brain stem Defects associated with SIDS 2Health News:Making Headway Against Hepatitis C 2Health News:Breast Cancer linked to Gene Risk 2
    ... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
    Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
    ... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
    ... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
    Medicine Products: